Krystal Biotech, Inc.
KRYS
$345.70
-$2.40-0.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 54.77M | 55.93M | 51.40M | 79.36M | 38.33M |
| Total Depreciation and Amortization | 366.00K | 726.00K | 762.00K | 512.00K | 543.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.03M | 13.64M | 15.85M | -12.34M | 13.36M |
| Change in Net Operating Assets | 5.62M | 10.08M | 9.50M | -27.88M | 494.00K |
| Cash from Operations | 74.79M | 80.38M | 77.51M | 39.66M | 52.73M |
| Capital Expenditure | -3.57M | -7.15M | -2.14M | -1.70M | -1.90M |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -158.02M | -56.44M | 13.30M | -2.58M | -8.62M |
| Cash from Investing | -161.58M | -63.58M | 11.16M | -4.29M | -10.53M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15.16M | 6.50M | 15.69M | 3.71M | 1.80M |
| Repurchase of Common Stock | -108.00K | -16.96M | -23.00K | -5.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.05M | -10.46M | 15.67M | 3.71M | 1.80M |
| Foreign Exchange rate Adjustments | -1.83M | -1.33M | -637.00K | -307.00K | 1.06M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.57M | 5.01M | 103.70M | 38.78M | 45.06M |